ArticleSubstance abuse treatment, prevention, and policy2026
Inpatient utilization among Medicaid members with substance use disorder in Oregon.
Article in Substance abuse treatment, prevention, and policy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn the United States, substance use disorders (SUDs) remain a critical public health concern with significant morbidity and mortality. Oregon exemplifies this crisis with high rates of illicit drug use and overdose deaths, compounded by systemic challenges like behavioral health workforce shortages. This study's objective is to characterize patterns of acute care utilization and ED visit and admission reasons among Medicaid enrollees with opioid use disorder, stimulant use disorder, and/or unintentional substance overdoses in the Portland metro area.
methodsWe conducted a cross-sectional analysis of 2023 Medicaid enrollment and claims data from Health Share of Oregon, a coordinated care organization. The study included adult Medicaid members (aged 18 to 65) enrolled in Health Share of Oregon for at least six months during 2023, categorized into cohorts based on ICD-10-CM diagnosis codes for opioid use disorder, stimulant use disorder, and unintentional substance overdoses. Members without these diagnoses served as a comparison group. Measures included rates per 1,000 member months, frequencies, and proportions of emergency department (ED) visits, avoidable ED visits, inpatient admissions, length of stay, readmissions, and hospitalizations for ambulatory care sensitive conditions, as well as reasons for ED visits and inpatient admissions.
resultsCompared to non-cohort members, individuals in the cohorts had significantly higher emergency department and inpatient utilization rates. Those with unintentional substance overdoses exhibited the highest rates. Cohort members had longer hospital stays, higher rates of 30-day readmissions, and increased avoidable ED visits and hospitalizations for ambulatory care sensitive conditions. Infection was identified as the most common reason for admission among cohort members.
conclusionsMedicaid enrollees with substance use disorders exhibit substantial acute care needs and face systemic challenges. Addressing these needs requires enhanced access to evidence-based SUD treatments across multiple care settings. These findings underscore the need for clinical and policy interventions to mitigate the intertwined crises of SUD and acute care conditions in vulnerable populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.